Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Palmar Hyperhidrosis: early-phase trial registry

1 of 3 indexed Palmar Hyperhidrosis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Palmar Hyperhidrosis: 3 US clinical trials tracked, 1 recruiting.

Palmar Hyperhidrosis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Pariser, Robert J., M.D., running 1 of these trials.

Enrollment posture brief

Registry condition palmar-hyperhidrosis

OPEN 1 | RECR 33% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Palmar Hyperhidrosis (this)33%
Open-enrollment share among volume-matched conditions near Palmar Hyperhidrosis

Palmar Hyperhidrosis lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Palmar Hyperhidrosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Palmar Hyperhidrosis is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Top Sponsors

Named interventions

Most-linked intervention names on Palmar Hyperhidrosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Glycopyrronium 2.4 % Medicated Cloth Drug
1 trials
Dexmecamylamine HCl Drug
1 trials
Polymer Skin Barrier Device
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Palmar Hyperhidrosis trials. A trial with sites in several states counts in each.

Virginia 2 trials
Texas 1 trials
Missouri 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Palmar Hyperhidrosis page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Palmar Hyperhidrosis condition card totals 3 registered trials; most-linked intervention Glycopyrronium 2.4 % Medicated Cloth; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.